Inhaler
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a front elevational view of an inhaler showing my new design;
FIG. 2 is a rear elevational view thereof;
FIG. 3 is a top plan view thereof;
FIG. 4 is a bottom plan view thereof;
FIG. 5 is a side elevational view thereof;
FIG. 6 is a side elevational view thereof, opposite that shown in FIG. 5; and,
FIG. 7 is a perspective view thereof.
Claims
The ornamental design for a inhaler, as shown and described.
Referenced Cited
U.S. Patent Documents
D189076 | October 1960 | Altman |
D342994 | January 4, 1994 | Rand et al. |
D452910 | January 8, 2002 | Braithwaite et al. |
6792945 | September 21, 2004 | Davies et al. |
20020170560 | November 21, 2002 | Young et al. |
20030172927 | September 18, 2003 | Young et al. |
20040035420 | February 26, 2004 | Davies et al. |
20040099676 | May 27, 2004 | Anderson et al. |
Patent History
Patent number: D514222
Type: Grant
Filed: Nov 12, 2003
Date of Patent: Jan 31, 2006
Assignee: Glaxo Group Limited (Greenford)
Inventors: Gregor John McLennan Anderson (Ware), Philip William Farr (Ware), Andrew Michael Kelly (Ware)
Primary Examiner: Ian Simmons
Attorney: James P. Riek
Application Number: 29/193,684
Type: Grant
Filed: Nov 12, 2003
Date of Patent: Jan 31, 2006
Assignee: Glaxo Group Limited (Greenford)
Inventors: Gregor John McLennan Anderson (Ware), Philip William Farr (Ware), Andrew Michael Kelly (Ware)
Primary Examiner: Ian Simmons
Attorney: James P. Riek
Application Number: 29/193,684
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)